Skip to main content

Table 3 Confusion matrix and statistics of the prediction model

From: Development of cardiac risk prediction model in patients with HER-2 positive breast cancer on trastuzumab therapy

Sensitivity

46%

Specificity

84%

Positive Predictive Value (PPV)

22%

Negative Predictive Value (NPV)

94%

Prevalence

9%

Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us